Cargando…
Andrographolide is an Alternative Treatment to Overcome Resistance in ER-Positive Breast Cancer via Cholesterol Biosynthesis Pathway
Oestrogen receptor (ER)-positive breast cancer is one of the common forms of breast cancer affecting women worldwide. ER-positive breast cancer patients are subjected to anti-oestrogen therapy such as selective oestrogen receptor modulator (SERM) and aromatase inhibitors (AIs). Recently, the emergen...
Autores principales: | Rajaratinam, Harishini, Nafi, Siti Norasikin Mohd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Penerbit Universiti Sains Malaysia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839656/ https://www.ncbi.nlm.nih.gov/pubmed/31728115 http://dx.doi.org/10.21315/mjms2019.26.5.2 |
Ejemplares similares
-
Cellular and Molecular Changes in MNU-Induced Breast Tumours Injected with PF4 or bFGF
por: Nafi, Siti Norasikin Mohd, et al.
Publicado: (2017) -
Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives
por: Rajaratinam, Harishini, et al.
Publicado: (2022) -
A Retrospective Hospital-Based Study of HMGCR Expression in HER2 IHC 2+ and 3+ Breast Cancer
por: Mohamed, Malisalaora, et al.
Publicado: (2021) -
Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis
por: Xu, Tong, et al.
Publicado: (2022) -
Passage Number of 4T1 Cells Influences the Development of Tumour and the Progression of Metastasis in 4T1 Orthotopic Mice
por: Rajaratinam, Harishini, et al.
Publicado: (2022)